brexucabtagene autoleucel
gilead sciences
['zuma-2', 'car-t', 'nhl', 'lymsm']
with respect to car-t for mcl, check out the cross-trial comparisons between zuma-2 and transcend nhl. #lymsm #tcellrx #asco22 
Heme/onc fellow. #lymsm & #mmsm patient-reported outcomes researcher. Founder of https://t.co/kN6qeGFEox, @inTrainingDoc & @inHouseMag. ??????